About 272,488 results

Contraceptive use boosted by enhanced counseling
Heidi Splete

May 23rd, 2022 - Contraceptive counseling and interventions beyond usual care significantly increased the use of contraceptives with no accompanying increase in sexually transmitted infections or reduction in condom use, based on data from a new meta-analysis. “Although effective contraception is available in the United States and guidelines support contraceptive care in clinical practice, providing contracepti.

Downtime? Enjoy it
Allan M. Block, MD

May 23rd, 2022 - Everything in medicine, and pretty much the universe, is based on averages. Average reduction of seizures, average blood levels, average response to treatment, average insurance reimbursement, average time spent with a new consult.

Doxycycline bests azithromycin for anorectal chlamydia in women
Marilynn Larkin

May 23rd, 2022 - NEW YORK (Reuters) – A one-week course of doxycycline was superior to a single dose of azithromycin in women with concurrent vaginal and anorectal chlamydia infection in an unblinded randomized controlled trial, mirroring previous results in men. Researchers suggest that doxycycline should be the first-line therapy for chlamydia infection in women.

AGA Clinical Practice Guideline: Diagnosis, treatment of rare hamartomatous polyposis
Will Pass, MDedge News

May 23rd, 2022 - A clinical practice guideline for the diagnosis and management of gastrointestinal hamartomatous polyposis syndromes has just been published by the U. S.

Advice from the Trenches on Type 2 Diabetes Care
Davida F. Kruger, MSN, APRN-BC, BC-ADM

May 23rd, 2022 - Davida F. Kruger, MSN, APN-BC, BC-ADM Ms.

Subcutaneous injection of diclofenac sodium is effective against acute migraine

May 23rd, 2022 - Key clinical point: Self-administered single-dose subcutaneous (SC) injection of diclofenac sodium (50 mg/mL) complexed with hydroxypropyl-β-cyclodextrin (HPβCD) is safe and effective for the treatment of acute migraine attacks in patients with moderate-to-severe migraine pain. Major finding: After 2 hours of injection, 46.

Low glycemic index diet helps heart patients lose weight

May 23rd, 2022 - Madrid, Spain – 23 May 2022: Eating low glycaemic index foods promotes a healthier body shape in patients with coronary artery disease, according to a study presented at ACNAP-EuroHeartCare Congress 2022, a scientific congress of the European Society of Cardiology (ESC).1 The glycaemic index (GI) ranks carbohydrate-containing foods according to how quickly they affect blood sugar levels. High G...

Bacterial cocktail, spores counter recurrent C. diff
Jim Kling

May 22nd, 2022 - SAN DIEGO – A novel combination of eight human commensal bacteria has shown efficacy in preventing recurrent Clostridioides difficile infections in high-risk populations. The cocktail of bacterial strains (VE303), produced under tightly-controlled conditions, is delivered in powdered form over a period of 14 days.

Taste buds can adapt to low salt diet

May 22nd, 2022 - Madrid, Spain – 22 May 2022: A taste adaptation intervention lowers salt intake and increases enjoyment of a sodium restricted diet in patients with hypertension, according to a small study presented at ACNAP-EuroHeartCare Congress 2022, a scientific congress of the European Society of Cardiology (ESC).1 “One of the major barriers to sticking to a low salt diet is that people do not like the ta...

Speech analysis app predicts worsening heart failure before symptom onset

May 21st, 2022 - Madrid, Spain – 21 May 2022: A voice analysis app used by heart failure patients at home recognises fluid in the lungs three weeks before an unplanned hospitalisation or escalation in outpatient drug treatment. The late breaking research is presented at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1 “The current standard of care just isn’t good enough fo...

Voice-Analysis App Promising as Early Warning System for Heart Failure Decompensation

May 21st, 2022 - A voice can carry a long distance, but in patients with heart failure (HF) a voice can also carry otherwise hidden signs useful for predicting short-term risk for worsening disease, even acute decompensation. Potentially, it only has to reach a smartphone to do it, suggests a preliminary study of a mobile app designed to alert patients and clinicians to such looming HF events, if possible in ti...

CRC Screening: Blood Test Accuracy Compared to Colonoscopy

May 21st, 2022 - The first prospective study to evaluate the accuracy of a blood test for people being screened for colorectal cancer (CRC) revealed a high sensitivity and specificity. At 90% specificity, the blood assay (Guardant Health) was 100% sensitive for detecting CRC. At 95% specificity, sensitivity was 88%. The blood assay detects circulating tumor DNA from cancer in the bloodstream, which is then anal...

Being unmarried is associated with a higher risk of death in heart failure patients

May 21st, 2022 - Madrid, Spain – 21 May 2022: Unmarried heart failure patients appear less confident in managing their condition and more socially limited compared to their married counterparts, according to research presented today at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1 These differences may have contributed to the worse long-term survival observed in unmarri...

20th anniversary and history of cosmetic botulinum toxin type A
Naissan O. Wesley, MD

May 20th, 2022 - Historical food-borne outbreaks of botulism and identification of Clostridium botulinum as the bacterium responsible have had an enormous impact in medicine related to its therapeutic and cosmetic uses. The timeline of botulinum toxin discovery began with deadly outbreaks related to contaminated food across Europe in the late 1700s, the largest of which occurred in 1793 in Wildebrad, in souther.

European committee recommends approval of baricitinib for severe alopecia areata
Doug Brunk

May 20th, 2022 - The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of baricitinib, a Janus kinase (JAK) inhibitor, for the treatment of adults with severe alopecia areata (AA). The development, which was announced in a May 20, 2022, press release from the manufacturer, Eli Lilly and Incyte, marks the first step toward European regulatory approva.

Trending Clinical Topic: Periodontal Disease

May 20th, 2022 - Each week, we identify one top search term, speculate about what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, share them with us on Twitter or Facebook.  The association between gum disease and significant comorbidities has been highlighted in several recent studies. From inflammatory disorders to neurologic disord...

Children with same-sex parents are socially well-adjusted

May 20th, 2022 - A study by Dr Mirjam Fischer and colleagues at the University of Cologne’s Institute of Sociology and Social Psychology (ISS) shows that children and adolescents with same-sex parents are just as well adjusted as those with different-sex parents. In this study, 62 six-to-sixteen-year-olds with same-sex parents were compared with 72 peers with different-sex parents regarding prosocial behaviour,...

Award for meta-analysis on the relationship between job stressors and burnout

May 20th, 2022 - Dr. Christina Guthier and Professor Christian Dormann of Johannes Gutenberg University Mainz (JGU) together with Professor Manuel Völkle of Humboldt-Universität zu Berlin have won the 2022 Schmidt-Hunter Meta-Analysis Award for their work on the reciprocal relationship between job stressors and burnout. The prize is awarded annually to the best meta-analysis published in the field of industrial...

Venous thromboembolism: Less recurrencies with low-dose apixaban compared to discontinuation of the anticoagulant after negative D-dimer

May 20th, 2022 - Bologna 8 April 2022 - Patients who have suffered from a first episode of unprovoked venous thromboembolism (VTE) have an eight times higher risk of recurrence if they stop treatment after repeated negative D-dimer tests, instead of continuing with low-dose anticoagulant (apixaban). These are the results of the APIDULCIS study presented at the 6th Conference of the Arianna Anticoagulation Found...

Peptide created by Brazilian group delays melanoma growth in animal trials

May 20th, 2022 - An article published in Scientific Reports describes a study demonstrating the effectiveness of a peptide developed by Brazilian scientists, called Rb4, to combat cancer progression in an animal model, especially malignant melanoma. The molecule holds promise for the treatment of drug-resistant tumors. Preclinical in vitro and in vivo trials indicated that Rb4 triggers necrosis in murine melano...